PL2470230T5 - Lepkosprężyste żele jako nowe wypełniacze - Google Patents

Lepkosprężyste żele jako nowe wypełniacze

Info

Publication number
PL2470230T5
PL2470230T5 PL10750046.4T PL10750046T PL2470230T5 PL 2470230 T5 PL2470230 T5 PL 2470230T5 PL 10750046 T PL10750046 T PL 10750046T PL 2470230 T5 PL2470230 T5 PL 2470230T5
Authority
PL
Poland
Prior art keywords
viscoelastic gels
novel fillers
fillers
novel
viscoelastic
Prior art date
Application number
PL10750046.4T
Other languages
English (en)
Other versions
PL2470230T3 (pl
Inventor
Matteo D'este
Davide Renier
Original Assignee
Fidia Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42046298&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2470230(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fidia Farmaceutici S.P.A. filed Critical Fidia Farmaceutici S.P.A.
Publication of PL2470230T3 publication Critical patent/PL2470230T3/pl
Publication of PL2470230T5 publication Critical patent/PL2470230T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/005—Processes for mixing polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/12—Powdering or granulating
    • C08J3/14—Powdering or granulating by precipitation from solutions
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2205/00—Polymer mixtures characterised by other features
    • C08L2205/02—Polymer mixtures characterised by other features containing two or more polymers of the same C08L -group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Sustainable Development (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL10750046.4T 2009-08-27 2010-08-25 Lepkosprężyste żele jako nowe wypełniacze PL2470230T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITPD2009A000246A IT1395392B1 (it) 2009-08-27 2009-08-27 Geli viscoelastici come nuovi filler
PCT/EP2010/005161 WO2011023355A2 (en) 2009-08-27 2010-08-25 Viscoelastic gels as novel fillers
EP10750046.4A EP2470230B2 (en) 2009-08-27 2010-08-25 Viscoelastic gels as novel fillers

Publications (2)

Publication Number Publication Date
PL2470230T3 PL2470230T3 (pl) 2015-02-27
PL2470230T5 true PL2470230T5 (pl) 2022-10-31

Family

ID=42046298

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10750046.4T PL2470230T5 (pl) 2009-08-27 2010-08-25 Lepkosprężyste żele jako nowe wypełniacze
PL14170084T PL2772273T3 (pl) 2009-08-27 2010-08-25 Lepkosprężyste żele jako nowe wypełniacze

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL14170084T PL2772273T3 (pl) 2009-08-27 2010-08-25 Lepkosprężyste żele jako nowe wypełniacze

Country Status (21)

Country Link
US (1) US8846640B2 (pl)
EP (2) EP2470230B2 (pl)
JP (1) JP5976537B2 (pl)
KR (1) KR101749660B1 (pl)
CN (2) CN102548590B (pl)
AU (1) AU2010288937B2 (pl)
BR (1) BR112012004157B8 (pl)
CA (2) CA2995957C (pl)
CY (2) CY1115628T1 (pl)
DK (2) DK2772273T3 (pl)
ES (2) ES2563160T3 (pl)
HR (2) HRP20140981T4 (pl)
HU (1) HUE026830T2 (pl)
IT (1) IT1395392B1 (pl)
MX (1) MX2012002364A (pl)
PL (2) PL2470230T5 (pl)
PT (1) PT2470230E (pl)
RU (2) RU2543329C2 (pl)
SI (2) SI2772273T1 (pl)
SM (1) SMT201600062B (pl)
WO (1) WO2011023355A2 (pl)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5670196B2 (ja) 2007-11-16 2015-02-18 バイセプト セラピューティクス、インク． 紫斑を治療する組成物および方法
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
ES2658609T3 (es) 2008-09-02 2018-03-12 Tautona Group Lp Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos, y usos de los mismos
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
KR101764451B1 (ko) 2010-03-12 2017-08-02 알러간 인더스트리 에스에이에스 피부 상태 개선을 위한 히알루론안 폴리머 및 만니톨을 포함하는 유체 조성물
EP3078388B1 (en) 2010-03-22 2019-02-20 Allergan, Inc. Cross-linked hydrogels for soft tissue augmentation
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
FR2968305B1 (fr) 2010-12-06 2014-02-28 Teoxane Procede de preparation d'un gel reticule
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
KR102238406B1 (ko) 2011-06-03 2021-04-08 알러간 인더스트리 에스에이에스 항산화제를 포함하는 피부 충전제 조성물
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
RU2613887C2 (ru) * 2011-08-10 2017-03-21 Гликорес 2000 С.Р.Л. Устойчивый к расщеплению сшитый низкомолекулярный гиалуронат
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
CN108379112A (zh) * 2011-09-14 2018-08-10 阿勒根公司 用于细纹治疗的真皮填充剂组合物
KR101428145B1 (ko) 2011-11-24 2014-08-08 (주)아모레퍼시픽 수불용성 겔 조성물 및 그 제조방법
ITPD20120098A1 (it) 2012-03-30 2013-10-01 Fidia Farmaceutici "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico"
ITMI20120732A1 (it) * 2012-05-03 2013-11-04 B S Srl Polisaccaridi reticolati a memoria di forma
BR112014031412B1 (pt) * 2012-06-15 2021-01-05 Merz Pharma Gmbh & Co. Kgaa método de preparação de uma composição
FR2997085B1 (fr) * 2012-10-24 2015-05-29 Teoxane Procede de preparation d'un gel reticule
ITPD20120360A1 (it) 2012-11-30 2014-05-31 Fidia Farmaceutici "nuovi geli viscoelastici in chirurgia oftalmica"
US20140315828A1 (en) 2013-04-22 2014-10-23 Allergan, Inc. Cross-linked silk-hyaluronic acid compositions
ITPD20130110A1 (it) * 2013-04-24 2014-10-25 Fidia Farmaceutici Composizioni farmaceutiche comprendenti acido ialuronico per il trattamento del black disc
HK1224315A1 (zh) * 2013-06-28 2017-08-18 Galderma S.A. 用於制备交联的透明质酸产物的方法
WO2015005345A1 (ja) * 2013-07-08 2015-01-15 電気化学工業株式会社 コアシェル型架橋ヒアルロン酸ゲル粒子、その製造方法及び医用材料
US9579257B2 (en) 2013-08-20 2017-02-28 Anutra Medical, Inc. Haptic feedback and audible output syringe
USD750768S1 (en) 2014-06-06 2016-03-01 Anutra Medical, Inc. Fluid administration syringe
USD774182S1 (en) 2014-06-06 2016-12-13 Anutra Medical, Inc. Anesthetic delivery device
USD763433S1 (en) 2014-06-06 2016-08-09 Anutra Medical, Inc. Delivery system cassette
EP3200838B1 (en) 2014-09-30 2019-09-18 Allergan Industrie, SAS Stable hydrogel compositions including additives
FR3029928B1 (fr) 2014-12-15 2018-03-09 Teoxane Gel reticule
HUE047971T2 (hu) 2015-02-13 2020-05-28 Allergan Ind Sas Az arcelemek - például az áll - formázására, megnagyobbítására vagy korrekciójára szolgáló implantátumok
RU2610006C1 (ru) * 2016-03-23 2017-02-07 Наталья Павловна Михайлова Способ липотерапии
EP3503841A4 (en) 2016-08-24 2020-04-22 Allergan, Inc. CO-CROSSLINKED HYALURONIC ACID-FIBROIN HYDROGELS FOR IMPROVING THE SUSTAINABILITY OF TISSUE GRAFTS AND FOR INCREASING SOFT TISSUES
JP2020516695A (ja) 2017-04-12 2020-06-11 ウリゲン ファーマシューティカルズ、インコーポレイテッド 改善された安定性を備えた注射器中に局所麻酔薬、緩衝液、およびグルコサミノグリカンを含む製品
WO2019121688A1 (en) 2017-12-22 2019-06-27 Nestlé Skin Health Sa Injectable gel product
EP3731808B1 (en) * 2017-12-29 2023-09-20 Matex Lab S.P.A. Method to prepare filler with a hyaluronic acid base comprising a neutralization step
IT201800001890A1 (it) 2018-01-25 2019-07-25 Fidia Farm Spa Composizioni farmaceutiche per il trattamento del dolore postoperatorio
WO2020116999A1 (ko) 2018-12-07 2020-06-11 한미약품 주식회사 히알루론산 가교물, 히알루론산 수화 겔 및 이들의 제조방법
KR102400586B1 (ko) * 2018-12-07 2022-05-23 한미약품 주식회사 히알루론산 가교물, 히알루론산 수화 겔 및 이들의 제조방법
EP3730161A4 (en) * 2019-03-08 2021-07-14 GCS Co., Ltd. COMPLEX PRODUCTION PROCESS
IT202000005692A1 (it) * 2020-03-17 2021-09-17 Fidia Farm Spa Bio-inchiostro per stampa 3D, relativo coniugato e processo di preparazione di un intermedio costituito da un linker fotoreattivo
KR102417671B1 (ko) * 2020-04-28 2022-07-06 충남대학교산학협력단 자가가교 시스템을 가지는 히알루론산 기반 연조직 충전 조성물 및 이의 제조방법
RU2746877C1 (ru) * 2020-07-23 2021-04-21 Роман Дмитриевич Лебедев Пористый фильтрующий элемент и способ его изготовления
KR102640893B1 (ko) * 2021-11-12 2024-02-27 주식회사 유영제약 히알루론산 가교물을 포함하는 조성물의 제조방법
TWI840941B (zh) * 2022-09-06 2024-05-01 科妍生物科技股份有限公司 製造自體交聯透明質酸凝膠之方法及其產物
KR20260014580A (ko) 2023-05-25 2026-01-30 메르츠 에스테틱스 게엠베하 에스테르 결합에 의해 상호연결된 다당류 모이어티를 포함하는 가교연결된 물질

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8501022L (sv) * 1985-03-01 1986-09-02 Pharmacia Ab Format alster och forfarande for dess framstellning
IT1198449B (it) 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5827937A (en) 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
IT1288290B1 (it) * 1996-06-21 1998-09-11 Fidia Spa In Amministrazione S Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie
IT1296689B1 (it) * 1997-11-06 1999-07-14 Fidia Advanced Biopolymers Srl Derivati esterei dell'acido ialuronico aventi proprieta viscoelastiche e loro uso in campo biomedico-sanitario
ITPD980169A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
IT1303735B1 (it) * 1998-11-11 2001-02-23 Falorni Italia Farmaceutici S Acidi ialuronici reticolati e loro usi medici.
IT1317358B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Derivati cross-linkati dell'acido ialuronico.
EP1750769B1 (en) 2004-05-20 2013-01-23 Mentor Worldwide LLC Methods for making injectable polymer hydrogels
ITPD20050056A1 (it) * 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
ITPD20050146A1 (it) * 2005-05-20 2006-11-21 Fidia Farmaceutici Fillers riassorbibili costituiti da liposomi e acido ialuronico e o suoi derivati
FR2909560B1 (fr) * 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
JP5165281B2 (ja) * 2007-06-01 2013-03-21 株式会社バイオベルデ ２反応剤型の医療用含水ゲル形成剤、及び、これより得られるヒアルロン酸ゲル
FR2918377B1 (fr) * 2007-07-05 2010-10-08 Estelle Piron Gel co-reticule de polysaccharides
ATE544786T1 (de) † 2007-09-28 2012-02-15 Shiseido Co Ltd Quellbares vernetztes hyaluronsäurepulver und herstellungsverfahren dafür
WO2009043111A1 (en) * 2007-10-04 2009-04-09 Ultraceuticals R & D Pty Ltd Composition and method for dermal regeneration
US8394782B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
FR2924615B1 (fr) * 2007-12-07 2010-01-22 Vivacy Lab Hydrogel cohesif biodegradable.
CN101878230B (zh) * 2007-12-19 2012-11-21 赢创高施米特有限公司 乳液中的交联透明质酸
CN101538377A (zh) † 2008-03-20 2009-09-23 上海昊海生物科技有限公司 一种交联透明质酸凝胶及其制备方法
US8357795B2 (en) * 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine

Also Published As

Publication number Publication date
ES2563160T3 (es) 2016-03-11
HK1196787A1 (en) 2014-12-24
KR101749660B1 (ko) 2017-06-21
HRP20140981T2 (hr) 2016-05-06
BR112012004157B8 (pt) 2021-06-22
ES2509225T5 (es) 2022-09-29
DK2772273T3 (en) 2016-03-07
KR20120107455A (ko) 2012-10-02
PL2772273T3 (pl) 2016-05-31
RU2012106800A (ru) 2013-08-27
CN104623730B (zh) 2016-11-16
PT2470230E (pt) 2014-10-07
EP2772273B9 (en) 2016-05-18
WO2011023355A3 (en) 2011-10-27
AU2010288937A1 (en) 2012-03-15
ES2509225T3 (es) 2014-10-17
ITPD20090246A1 (it) 2011-02-28
SI2470230T1 (sl) 2014-11-28
SI2772273T1 (sl) 2016-04-29
CA2995957A1 (en) 2011-03-03
HUE026830T2 (en) 2016-07-28
EP2772273A3 (en) 2014-12-03
RU2692800C2 (ru) 2019-06-27
MX2012002364A (es) 2012-03-29
RU2014149799A (ru) 2016-07-10
JP2013502941A (ja) 2013-01-31
CA2772142C (en) 2018-04-10
CA2772142A1 (en) 2011-03-03
HRP20140981T8 (en) 2015-01-16
JP5976537B2 (ja) 2016-08-23
CN102548590A (zh) 2012-07-04
CN104623730A (zh) 2015-05-20
EP2772273B1 (en) 2015-12-02
SMT201600062B (it) 2016-04-29
DK2470230T3 (da) 2014-10-06
EP2470230B1 (en) 2014-07-23
CA2995957C (en) 2020-04-28
PL2470230T3 (pl) 2015-02-27
EP2470230B2 (en) 2022-07-06
RU2014149799A3 (pl) 2018-08-28
BR112012004157B1 (pt) 2021-03-09
SI2470230T2 (sl) 2022-09-30
US20120190644A1 (en) 2012-07-26
HRP20160196T1 (hr) 2016-03-25
HRP20140981T1 (en) 2014-11-21
WO2011023355A2 (en) 2011-03-03
EP2772273A2 (en) 2014-09-03
CY1117207T1 (el) 2017-04-05
BR112012004157A2 (pt) 2020-08-11
CN102548590B (zh) 2015-02-25
HK1172850A1 (en) 2013-05-03
US8846640B2 (en) 2014-09-30
DK2470230T4 (da) 2022-08-01
AU2010288937B2 (en) 2015-03-05
RU2543329C2 (ru) 2015-02-27
CY1115628T1 (el) 2017-01-04
IT1395392B1 (it) 2012-09-14
EP2470230A2 (en) 2012-07-04
HRP20140981T4 (hr) 2022-08-19

Similar Documents

Publication Publication Date Title
PL2470230T3 (pl) Lepkosprężyste żele jako nowe wypełniacze
PL2393812T3 (pl) Podstawione spiroamidy jako modulatory B1R
IL217881A0 (en) Polymer compositions
GB0905863D0 (en) Novel composition
IL213794A0 (en) Novel uses
GB0910046D0 (en) Novel compositions
IL220616A0 (en) Novel 3 - hydroxy - 5 - arylisothiazole derivative
ZA201109176B (en) Homeglobin compositions
IL217949A0 (en) Pesticdal compositions
EP2495238A4 (en) NEW 3-HYDROXY-5-ARYLISOXAZOLE DERIVATIVE
GB0906515D0 (en) Fungical compositions
PL2516474T3 (pl) Modyfikowane kompozycje polimerowe
PL2516478T3 (pl) Modyfikowane kompozycje polimerowe
ZA201109312B (en) Compositions
ZA201109437B (en) Novel azabicyclohexanes
IL214232A0 (en) Novel tricyanoborates
GB0910045D0 (en) Novel compositions
IL213672A0 (en) Aroylamino-and heteroaroylamino-substituted piperidines as glyt-1 inhibitors
GB0917736D0 (en) Gel composition
GB0905165D0 (en) Compositions
GB2483195B (en) Novel uses
GB0912768D0 (en) Novel composition
GB0921967D0 (en) Novel Aryloxyanilide Derivatives
GB0908963D0 (en) Compositions
GB0900288D0 (en) Novel compositions